Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

Lorena Landuzzi, Marianna L. Ianzano, Giordano Nicoletti, Arianna Palladini, Valentina Grosso, Dario Ranieri, Massimiliano Dall'Ora, Elena Raschi, Roberta Laranga, Marco Gambarotti, Piero Picci, Carla de Giovanni, Patrizia Nanni, Pier Luigi Lollini

Research output: Contribution to journalArticle

Abstract

Homozygous knockout of p53 in mice leads to early mortality from lymphoma, with almost complete penetrance, thus hampering studies of other tumor histotypes related to p53 alterations. To avoid lymphoma development, we crossed p53 knockout mice (BALB-p53 mice) with alymphocytic BALB/c Rag2-/-;Il2rg-/- (RGKO) mice. We compared the tumor spectrum of homozygous (BALB-p53-/-) and heterozygous (BALB-p53-/-) mice with alymphocytic mice (RGKO-p53-/- and RGKO-p53-/-). Lymphoma incidence in BALB-p53-/- mice exceeded 80%, whereas in RGKO-p53-/- it was strongly reduced. The prevalent tumor of RGKO-p53-/- mice was hemangiosarcoma (incidence over 65% in both sexes, mean latency 18 weeks), other tumors included soft tissue sarcomas (incidence ∼10%), lung and mammary carcinomas. Tumor spectrum changes occurred also in p53 heterozygotes, in which lymphomas are relatively rare (∼20%). RGKO-p53-/- had an increased incidence of hemangiosarcomas, reaching ∼30%, and females had an increased incidence of osteosarcomas, reaching ∼20%. Osteosarcomas shared with the corresponding human tumors the involvement of limbs and a high metastatic ability, mainly to the lungs. Specific alterations in the expression of p53-related genes (p16Ink4a, p19Arf, p15Ink4b, p21Cip1) were observed. Genetic prevention of lymphoma in p53 knockout mice led to new models of sarcoma development, available for studies on hemangiosarcoma and osteosarcoma onset and metastatization.

Original languageEnglish
Pages (from-to)11924-11938
Number of pages15
JournalOncotarget
Volume5
Issue number23
Publication statusPublished - 2014

Fingerprint

Knockout Mice
Sarcoma
Lymphoma
Hemangiosarcoma
Osteosarcoma
Incidence
Neoplasms
Lung
Penetrance
p53 Genes
Heterozygote
Extremities
Breast Neoplasms
Mortality

Keywords

  • Hemangiosarcoma
  • Lymphoma
  • Osteosarcoma
  • p53-KO mice
  • Rag2KO/Il2rgKO mice

ASJC Scopus subject areas

  • Oncology

Cite this

Landuzzi, L., Ianzano, M. L., Nicoletti, G., Palladini, A., Grosso, V., Ranieri, D., ... Lollini, P. L. (2014). Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas. Oncotarget, 5(23), 11924-11938.

Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas. / Landuzzi, Lorena; Ianzano, Marianna L.; Nicoletti, Giordano; Palladini, Arianna; Grosso, Valentina; Ranieri, Dario; Dall'Ora, Massimiliano; Raschi, Elena; Laranga, Roberta; Gambarotti, Marco; Picci, Piero; de Giovanni, Carla; Nanni, Patrizia; Lollini, Pier Luigi.

In: Oncotarget, Vol. 5, No. 23, 2014, p. 11924-11938.

Research output: Contribution to journalArticle

Landuzzi, L, Ianzano, ML, Nicoletti, G, Palladini, A, Grosso, V, Ranieri, D, Dall'Ora, M, Raschi, E, Laranga, R, Gambarotti, M, Picci, P, de Giovanni, C, Nanni, P & Lollini, PL 2014, 'Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas', Oncotarget, vol. 5, no. 23, pp. 11924-11938.
Landuzzi, Lorena ; Ianzano, Marianna L. ; Nicoletti, Giordano ; Palladini, Arianna ; Grosso, Valentina ; Ranieri, Dario ; Dall'Ora, Massimiliano ; Raschi, Elena ; Laranga, Roberta ; Gambarotti, Marco ; Picci, Piero ; de Giovanni, Carla ; Nanni, Patrizia ; Lollini, Pier Luigi. / Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas. In: Oncotarget. 2014 ; Vol. 5, No. 23. pp. 11924-11938.
@article{41c9236b81524b568b0835db0244a24a,
title = "Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas",
abstract = "Homozygous knockout of p53 in mice leads to early mortality from lymphoma, with almost complete penetrance, thus hampering studies of other tumor histotypes related to p53 alterations. To avoid lymphoma development, we crossed p53 knockout mice (BALB-p53 mice) with alymphocytic BALB/c Rag2-/-;Il2rg-/- (RGKO) mice. We compared the tumor spectrum of homozygous (BALB-p53-/-) and heterozygous (BALB-p53-/-) mice with alymphocytic mice (RGKO-p53-/- and RGKO-p53-/-). Lymphoma incidence in BALB-p53-/- mice exceeded 80{\%}, whereas in RGKO-p53-/- it was strongly reduced. The prevalent tumor of RGKO-p53-/- mice was hemangiosarcoma (incidence over 65{\%} in both sexes, mean latency 18 weeks), other tumors included soft tissue sarcomas (incidence ∼10{\%}), lung and mammary carcinomas. Tumor spectrum changes occurred also in p53 heterozygotes, in which lymphomas are relatively rare (∼20{\%}). RGKO-p53-/- had an increased incidence of hemangiosarcomas, reaching ∼30{\%}, and females had an increased incidence of osteosarcomas, reaching ∼20{\%}. Osteosarcomas shared with the corresponding human tumors the involvement of limbs and a high metastatic ability, mainly to the lungs. Specific alterations in the expression of p53-related genes (p16Ink4a, p19Arf, p15Ink4b, p21Cip1) were observed. Genetic prevention of lymphoma in p53 knockout mice led to new models of sarcoma development, available for studies on hemangiosarcoma and osteosarcoma onset and metastatization.",
keywords = "Hemangiosarcoma, Lymphoma, Osteosarcoma, p53-KO mice, Rag2KO/Il2rgKO mice",
author = "Lorena Landuzzi and Ianzano, {Marianna L.} and Giordano Nicoletti and Arianna Palladini and Valentina Grosso and Dario Ranieri and Massimiliano Dall'Ora and Elena Raschi and Roberta Laranga and Marco Gambarotti and Piero Picci and {de Giovanni}, Carla and Patrizia Nanni and Lollini, {Pier Luigi}",
year = "2014",
language = "English",
volume = "5",
pages = "11924--11938",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "23",

}

TY - JOUR

T1 - Genetic prevention of lymphoma in p53 knockout mice allows the early development of p53-related sarcomas

AU - Landuzzi, Lorena

AU - Ianzano, Marianna L.

AU - Nicoletti, Giordano

AU - Palladini, Arianna

AU - Grosso, Valentina

AU - Ranieri, Dario

AU - Dall'Ora, Massimiliano

AU - Raschi, Elena

AU - Laranga, Roberta

AU - Gambarotti, Marco

AU - Picci, Piero

AU - de Giovanni, Carla

AU - Nanni, Patrizia

AU - Lollini, Pier Luigi

PY - 2014

Y1 - 2014

N2 - Homozygous knockout of p53 in mice leads to early mortality from lymphoma, with almost complete penetrance, thus hampering studies of other tumor histotypes related to p53 alterations. To avoid lymphoma development, we crossed p53 knockout mice (BALB-p53 mice) with alymphocytic BALB/c Rag2-/-;Il2rg-/- (RGKO) mice. We compared the tumor spectrum of homozygous (BALB-p53-/-) and heterozygous (BALB-p53-/-) mice with alymphocytic mice (RGKO-p53-/- and RGKO-p53-/-). Lymphoma incidence in BALB-p53-/- mice exceeded 80%, whereas in RGKO-p53-/- it was strongly reduced. The prevalent tumor of RGKO-p53-/- mice was hemangiosarcoma (incidence over 65% in both sexes, mean latency 18 weeks), other tumors included soft tissue sarcomas (incidence ∼10%), lung and mammary carcinomas. Tumor spectrum changes occurred also in p53 heterozygotes, in which lymphomas are relatively rare (∼20%). RGKO-p53-/- had an increased incidence of hemangiosarcomas, reaching ∼30%, and females had an increased incidence of osteosarcomas, reaching ∼20%. Osteosarcomas shared with the corresponding human tumors the involvement of limbs and a high metastatic ability, mainly to the lungs. Specific alterations in the expression of p53-related genes (p16Ink4a, p19Arf, p15Ink4b, p21Cip1) were observed. Genetic prevention of lymphoma in p53 knockout mice led to new models of sarcoma development, available for studies on hemangiosarcoma and osteosarcoma onset and metastatization.

AB - Homozygous knockout of p53 in mice leads to early mortality from lymphoma, with almost complete penetrance, thus hampering studies of other tumor histotypes related to p53 alterations. To avoid lymphoma development, we crossed p53 knockout mice (BALB-p53 mice) with alymphocytic BALB/c Rag2-/-;Il2rg-/- (RGKO) mice. We compared the tumor spectrum of homozygous (BALB-p53-/-) and heterozygous (BALB-p53-/-) mice with alymphocytic mice (RGKO-p53-/- and RGKO-p53-/-). Lymphoma incidence in BALB-p53-/- mice exceeded 80%, whereas in RGKO-p53-/- it was strongly reduced. The prevalent tumor of RGKO-p53-/- mice was hemangiosarcoma (incidence over 65% in both sexes, mean latency 18 weeks), other tumors included soft tissue sarcomas (incidence ∼10%), lung and mammary carcinomas. Tumor spectrum changes occurred also in p53 heterozygotes, in which lymphomas are relatively rare (∼20%). RGKO-p53-/- had an increased incidence of hemangiosarcomas, reaching ∼30%, and females had an increased incidence of osteosarcomas, reaching ∼20%. Osteosarcomas shared with the corresponding human tumors the involvement of limbs and a high metastatic ability, mainly to the lungs. Specific alterations in the expression of p53-related genes (p16Ink4a, p19Arf, p15Ink4b, p21Cip1) were observed. Genetic prevention of lymphoma in p53 knockout mice led to new models of sarcoma development, available for studies on hemangiosarcoma and osteosarcoma onset and metastatization.

KW - Hemangiosarcoma

KW - Lymphoma

KW - Osteosarcoma

KW - p53-KO mice

KW - Rag2KO/Il2rgKO mice

UR - http://www.scopus.com/inward/record.url?scp=84919969092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919969092&partnerID=8YFLogxK

M3 - Article

C2 - 25426555

AN - SCOPUS:84919969092

VL - 5

SP - 11924

EP - 11938

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 23

ER -